vs

Side-by-side financial comparison of GLAUKOS Corp (GKOS) and LXP Industrial Trust (LXP). Click either name above to swap in a different company.

GLAUKOS Corp is the larger business by last-quarter revenue ($150.6M vs $86.7M, roughly 1.7× LXP Industrial Trust). LXP Industrial Trust runs the higher net margin — 33.2% vs 6.2%, a 26.9% gap on every dollar of revenue. On growth, GLAUKOS Corp posted the faster year-over-year revenue change (41.2% vs -14.0%). Over the past eight quarters, GLAUKOS Corp's revenue compounded faster (25.4% CAGR vs 0.3%).

Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.

LXP Industrial Trust is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality industrial real estate assets, primarily distribution centers, logistics facilities, and light industrial properties across key markets in the United States. Its tenant base covers e-commerce, third-party logistics, and advanced manufacturing sectors, delivering stable long-term returns for its investors.

GKOS vs LXP — Head-to-Head

Bigger by revenue
GKOS
GKOS
1.7× larger
GKOS
$150.6M
$86.7M
LXP
Growing faster (revenue YoY)
GKOS
GKOS
+55.2% gap
GKOS
41.2%
-14.0%
LXP
Higher net margin
LXP
LXP
26.9% more per $
LXP
33.2%
6.2%
GKOS
Faster 2-yr revenue CAGR
GKOS
GKOS
Annualised
GKOS
25.4%
0.3%
LXP

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
GKOS
GKOS
LXP
LXP
Revenue
$150.6M
$86.7M
Net Profit
$9.4M
$28.8M
Gross Margin
77.9%
81.5%
Operating Margin
9.0%
34.6%
Net Margin
6.2%
33.2%
Revenue YoY
41.2%
-14.0%
Net Profit YoY
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GKOS
GKOS
LXP
LXP
Q1 26
$150.6M
Q4 25
$143.1M
$86.7M
Q3 25
$133.5M
$86.9M
Q2 25
$124.1M
$87.7M
Q1 25
$106.7M
$88.9M
Q4 24
$105.5M
$100.9M
Q3 24
$96.7M
$85.6M
Q2 24
$95.7M
$85.8M
Net Profit
GKOS
GKOS
LXP
LXP
Q1 26
$9.4M
Q4 25
$-133.7M
$28.8M
Q3 25
$-16.2M
$36.3M
Q2 25
$-19.7M
$29.1M
Q1 25
$-18.1M
$19.0M
Q4 24
$-33.6M
Q3 24
$-21.4M
$6.3M
Q2 24
$-50.5M
$5.4M
Gross Margin
GKOS
GKOS
LXP
LXP
Q1 26
77.9%
Q4 25
-1.1%
81.5%
Q3 25
78.4%
82.3%
Q2 25
78.3%
81.9%
Q1 25
77.2%
80.7%
Q4 24
72.9%
85.3%
Q3 24
76.6%
82.5%
Q2 24
76.4%
82.0%
Operating Margin
GKOS
GKOS
LXP
LXP
Q1 26
9.0%
Q4 25
-97.7%
34.6%
Q3 25
-12.3%
50.4%
Q2 25
-18.3%
33.7%
Q1 25
-19.4%
21.8%
Q4 24
-27.2%
Q3 24
-25.5%
7.9%
Q2 24
-31.3%
6.9%
Net Margin
GKOS
GKOS
LXP
LXP
Q1 26
6.2%
Q4 25
-93.4%
33.2%
Q3 25
-12.2%
41.7%
Q2 25
-15.8%
33.2%
Q1 25
-17.0%
21.4%
Q4 24
-31.8%
Q3 24
-22.1%
7.4%
Q2 24
-52.8%
6.3%
EPS (diluted)
GKOS
GKOS
LXP
LXP
Q1 26
Q4 25
$-2.34
Q3 25
$-0.28
$0.12
Q2 25
$-0.34
$0.09
Q1 25
$-0.32
$0.06
Q4 24
$-0.56
Q3 24
$-0.39
$0.02
Q2 24
$-1.00
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GKOS
GKOS
LXP
LXP
Cash + ST InvestmentsLiquidity on hand
$276.7M
$170.4M
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$670.9M
$2.0B
Total Assets
$893.3M
$3.5B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GKOS
GKOS
LXP
LXP
Q1 26
$276.7M
Q4 25
$90.8M
$170.4M
Q3 25
$98.2M
$229.7M
Q2 25
$100.8M
$71.0M
Q1 25
$114.3M
$70.9M
Q4 24
$169.6M
$101.8M
Q3 24
$100.1M
$55.0M
Q2 24
$68.1M
$48.7M
Total Debt
GKOS
GKOS
LXP
LXP
Q1 26
Q4 25
$1.4B
Q3 25
$1.5B
Q2 25
$1.5B
Q1 25
$1.5B
Q4 24
$1.6B
Q3 24
Q2 24
Stockholders' Equity
GKOS
GKOS
LXP
LXP
Q1 26
$670.9M
Q4 25
$656.2M
$2.0B
Q3 25
$769.5M
$2.1B
Q2 25
$765.1M
$2.1B
Q1 25
$764.0M
$2.1B
Q4 24
$766.9M
$2.1B
Q3 24
$668.5M
$2.1B
Q2 24
$665.2M
$2.1B
Total Assets
GKOS
GKOS
LXP
LXP
Q1 26
$893.3M
Q4 25
$893.5M
$3.5B
Q3 25
$999.4M
$3.7B
Q2 25
$987.0M
$3.7B
Q1 25
$966.2M
$3.8B
Q4 24
$974.8M
$3.8B
Q3 24
$926.5M
$3.9B
Q2 24
$919.7M
$3.9B
Debt / Equity
GKOS
GKOS
LXP
LXP
Q1 26
Q4 25
0.66×
Q3 25
0.72×
Q2 25
0.72×
Q1 25
0.73×
Q4 24
0.75×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GKOS
GKOS
LXP
LXP
Operating Cash FlowLast quarter
$188.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
6.56×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GKOS
GKOS
LXP
LXP
Q1 26
Q4 25
$6.8M
$188.7M
Q3 25
$-10.1M
$63.5M
Q2 25
$7.0M
$44.3M
Q1 25
$-18.5M
$39.0M
Q4 24
$507.0K
$211.2M
Q3 24
$-9.6M
$64.6M
Q2 24
$-18.4M
$38.5M
Free Cash Flow
GKOS
GKOS
LXP
LXP
Q1 26
Q4 25
$3.9M
Q3 25
$-11.7M
Q2 25
$5.8M
Q1 25
$-20.5M
Q4 24
$-1.2M
Q3 24
$-11.0M
Q2 24
$-20.5M
FCF Margin
GKOS
GKOS
LXP
LXP
Q1 26
Q4 25
2.7%
Q3 25
-8.8%
Q2 25
4.7%
Q1 25
-19.2%
Q4 24
-1.2%
Q3 24
-11.4%
Q2 24
-21.4%
Capex Intensity
GKOS
GKOS
LXP
LXP
Q1 26
Q4 25
2.0%
Q3 25
1.2%
Q2 25
0.9%
Q1 25
1.8%
Q4 24
1.6%
Q3 24
1.5%
Q2 24
2.2%
Cash Conversion
GKOS
GKOS
LXP
LXP
Q1 26
Q4 25
6.56×
Q3 25
1.75×
Q2 25
1.52×
Q1 25
2.05×
Q4 24
Q3 24
10.18×
Q2 24
7.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons